A study conducted by researchers at the University of Florida and the University of South Florida Polytechnic, with assistance from Abbot Laboratories, has found that pharmaceutical products containing biologics (medicinal products created by biological processes), such as insulin and vaccines, were not adversely affected by 24-hour exposure to 8-watt RF signals, at frequencies typically employed by RFID readers and tags.
The project was led by Ismail Uysal, a professorat USFP's College of Technology and Innovation, and Jean-Pierre Emond, the dean of the College of Technology and Innovation. The researchers tested 100 biologic products manufactured by eight pharmaceutical companies, exposing those products to five different RF bands commonly used by RFID tags and readers: 13.56 MHz, 433 MHz, 868 MHz, 915 MHz and 2.4 GHz.
